ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Materials

Gelest invests in contact lens firm OcuMedic

by Michael McCoy
October 19, 2019 | APPEARED IN VOLUME 97, ISSUE 41

 

The specialty chemical maker Gelest has invested an undisclosed sum in OcuMedic, a New Jersey–based firm developing a drug-eluting soft contact lens that can replace eye drops. As part of the deal, Gelest will be OcuMedic’s exclusive supplier of acrylic monomers and reactive siloxanes used to produce the lenses. Gelest added to its silicone chemistry base in June when it acquired Bimax, a specialty acrylic monomer firm.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment